GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast Cancer
Clinical trial NCT05575804 · RECRUITING
Trial details
- NCT number
- NCT05575804
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2028-12-31
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.